The device is a first step for Healionics, which is also researching whether its Sphere Templated Angiogenic Regeneration technology could also be used in obesity management, diabetes care, advanced wound care and other human-related conditions.
Healionics raised $2.6 million in December from angel investment groups, bringing total funding to $4.3 million. Meanwhile, Xconomy reports that Michel Alvarez has assumed the CEO post from Rob Brown.
“We are very excited to announce the first commercial shipment of STAR, which is a significant milestone for Healionics and represents the Company’s first revenue from product sales," said Michel Alvarez in a statement.
READ MORE and COMMENT
," name="head">
<![CDATA[<body>
<script language=javascript type="text/javascript">
<!--
if (parent.frames.length)
top.location.href= document.location;
// -->
</script>
</head>
<frameset rows="34,*" frameborder=0>
<frame src="./tiny_templates_c/connect_head.php?wid=67860&cat=Business&url=http://feedproxy.google.com/~r/TechFlash/~3/2Spa16UBD9g/Healionics_unveils_glaucoma_treatment__for_dogs__41751082.html&urltitle=Healionics helps introduce glaucoma implant for dogs&description=<p>As Americans grow more connected to dogs and cats, a new market is developing to provide additional health care services to pets.</p><p>Witness the new offering from <a href="http://www.healionics.com/index.html">Healionics</a>. The Redmond startup today announced that its STAR biomaterial was being used in a new product to treat glaucoma in dogs. The TR-ClarifEYE - built in conjunction with Chandler, Arizona-based TR-BioSurgical -- is described as a "glaucoma implant" that improves tissue integration.</p><p>The device is a first step for Healionics, which is also researching whether its Sphere Templated Angiogenic Regeneration technology could also be used in obesity management, diabetes care, advanced wound care and other human-related conditions. </p><p>Healionics raised $2.6 million in December from angel investment groups, bringing total funding to $4.3 million. Meanwhile, Xconomy <a href="http://www.xconomy.com/seattle/2009/03/24/healionics-ships-first-product-for-glaucoma-device-in-dogs-appoints-new-ceo/">reports</a> that Michel Alvarez has assumed the CEO post from Rob Brown.</p><p>“We are very excited to announce the first commercial shipment of STAR, which is a significant milestone for Healionics and represents the Company’s first revenue from product sales," said Michel Alvarez in a statement.</p> <br /> <a href="http://www.techflash.com/Healionics_unveils_glaucoma_treatment__for_dogs__41751082.html">READ MORE and COMMENT</a><img src="http://feeds2.feedburner.com/~r/TechFlash/~4/2Spa16UBD9g" height="1" width="1"/>," name="head">
<frame src="http://feedproxy.google.com/~r/TechFlash/~3/2Spa16UBD9g/Healionics_unveils_glaucoma_treatment__for_dogs__41751082.html" name="Body">
</frameset>
</body>]]>